1. Home
  2. Live Updates
  3. Onclive

Live Breaking News & Updates on Onclive

Stay informed with the latest breaking news from Onclive on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Onclive and stay connected to the pulse of your community

Dr Kenderian on the Efficacy of Liso-Cel in R/R CLL/SLL

Saad J. Kenderian, MB, CHB, consultant, discusses the safety and efficacy findings derived from the phase 1/2 TRANSCEND CLL 004 study in CLL/SLL.

Saadj-kenderian , Department-of-immunology , Division-of-hematology , Department-of-internal-medicine , Department-of-molecular-medicine , Internal-medicine , Molecular-medicine , Mayo-clinic , Hronic-lymphocytic-leukemia , Sll , Cll

Leveraging Immunotherapy in GI Malignancies: Assays for Early Detection and Prevention

In this episode of OncChats: Leveraging Immunotherapy in GI Malignancies, experts explain the challenges faced with preventing or detecting these cancers early and the understanding needed to develop effective early detection methods and move the needle forward.

Arizona , United-states , Madappa-kundranda , Toufic-kachaamy , Sunil-sharma , National-institutes-of-health , Banner-md-anderson-cancer-center , Cancer-center , National-institutes , Immunotherapy , Gastrointestinal-cancer , Gi-malignancies

Leveraging Immunotherapy in GI Malignancies: A Shift in Drug Discovery

In this episode of OncChats: Leveraging Immunotherapy in GI Malignancies, experts discuss the potential benefits of utilizing immunotherapy approaches earlier on in the disease course.

Toufic-kachaamy , Madappa-kundranda , Sunil-sharma , Banner-md-anderson-cancer-center , Cancer-center , Nobel-prize , Immunotherapy , Gastrointestinal-malignancies , Gastrointestinal-cancer , Early-cancer , Gi-oncology , D

Dr Hafez on the Influence of Biomarker Expression on Adjuvant T-DM1 Use in HER2+ Breast Cancer

Maria Hafez, MD, discusses differences in biomarker expression prior to and following neoadjuvant chemotherapy treatment in HER2-positive breast cancer.

Maria-hafez , Breast-cancer-clinical-research , Sidney-kimmel-medical-college , Thomas-jefferson-university , Sidney-kimmel-cancer-center , Prediction-analysis , Absolute-intrinsic-molecular-subtyping , D , Onclive , Early-stage-her2-positive-breast-cancer- ,

Dr Arner on the Role of SETD2 Loss in Tumor Growth and Metastasis in ccRCC

Emily Arner, PhD, discusses research on the role of SETD2 loss in metastatic clear cell renal cell carcinoma ccRCC.

Emily-arner , Vanderbilt-university-medical-center , Division-of-hematology-oncology , Onclive , Ccrcc- , Setd2 , Renal-cell-carcinoma , Tumor-microenvironment , Mouse-model ,

Dr Hafez on Key Considerations For Treatment Selection in Early-Stage HER2+ Breast Cancer

Maria Hafez, MD, discusses how hormone receptor status, risk stratification, and other disease factors influence the treatment decision-making process in patients with early-stage HER2-positive breast cancer.

Maria-hafez , Key-considerations-for-treatment-selection , Partnership-with , D , Onclive , Early-stage-her2-positive-breast-cancer- ,

Lung Specialist Finds His "Sweet Spot" at the Intersection of Medicine and Technology

David P. Carbone, MD, PhD, sought to transform lung cancer care and did it—but didn’t anticipate the personal journey it would put him on.

Johns-hopkins-university , Maryland , United-states , Tennessee , Vienna , Wien , Austria , Massachusetts , Egypt , Texas , Ohio , University-of-texas-southwestern-medical-center

Knocking Expectations Out of the Park in the Search for a Cure

Dedication to his patients and the field of hematology spanning decades has led Stephen J. Forman, MD, to break down barriers for treating patients with leukemia and lymphoma.

United-states , Texas , Los-angeles , California , Dodger-stadium , Reunion , Frederick-appelbaum , Larry-kwak , Behnam-badie , Lior-goldberg , Tanya-siddiqi , Don-diamond

Assessing the Promise of AI in Oncology: Looking to the Future

In this final episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, discuss a roadmap of artificial intelligence (AI) advances in the next 5 to 10 years.

Toufica-kachaamy , Douglas-flora , Oncchats , Onclive , City-of-hope , St-elizabeth-healthcare , D , Ssbb , Accc , Precision-medicine , Artificial-intelligence

Assessing the Promise of AI in Oncology: Improving Patient Interactions and Experience

In this seventh episode of OncChats: Assessing the Promise of AI in Oncology, Toufic A. Kachaamy, MD, and Douglas Flora, MD, LSSBB, FACCC, discuss how artificial intelligence tools may be utilized to improve wait time for treatment, to provide more time for provider-patient interactions, and more.

Japan , Japanese , Toufica-kachaamy , Douglas-flora , Japanese-journal , Artificial-intelligence , Ai , Oncchats , Onclive , D , Ssbb